Genedrive Share Discussion Threads

[neo26] 08/2/2021 10:20

Why Investec Wealth and Investment sold shares?

[bunz3] 08/2/2021 10:19

buying building again

[hooded claw] 08/2/2021 10:11

aviator is always the one who misses out

[theaviator] 08/2/2021 10:10

Just looking at this. Think will wait for the handle though...

[hazl] 08/2/2021 10:03

Lots of late trades reported to confuse.

[qs99] 08/2/2021 10:02

Agreed Bunz

[billthebank] 08/2/2021 09:52

TR1 today should take us into 120s IMO

[bunz3] 08/2/2021 09:51

lloks like so many who have read this rns wanting in for mid month


Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing





The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations.

[hooded claw] 08/2/2021 09:47

£3 a share is £190m market cap which is £63m in revenue. Supplying 1 i7 is £7.5m in revenue.

[hooded claw] 08/2/2021 09:44

RV2, all I can say is you can't work a calculator.

[hazl] 08/2/2021 09:44

As expected in demand.

[seball] 08/2/2021 09:42

MMs need your shares. Hold and Buy any dips this is going above 200p easily. Strong Buy

[losses] 08/2/2021 09:33

Not really I was invested in Avacta nothing was happening so moved on!No emotions just like to try and make money

[ny boy] 08/2/2021 09:31

Aye, an easy hold, been accumulating (FOXT),which had become oversold,imo

Good markets for accumulating

[hodhasharon] 08/2/2021 09:29

200p will be hit this week IMHO. The solution is 100%, and the demand is there.

[rv2] 08/2/2021 09:26

That's ramping to the next level...don't get carried away. More realistic target medium to long term is £3

[hodhasharon] 08/2/2021 09:05

Don't look back and regret life-changing decisions. GDR could easily achieve a £10, or even £100 per share. The scope of Covid testing is huge, and a perfect launchpad for other tests in the GDR portfolio.

[billthebank] 08/2/2021 09:03

Nothing stopping this share

[bunz3] 08/2/2021 09:02

QS99 ,yes looks like more who have read rns loading up with shares as getting closer to mid month

be good if some sellers at this level ,important to see as many sellers out as possible at each level share price moves up to
for people who investing with a longer term view

[yasyas1] 08/2/2021 09:01

Ohh nice start

[hazl] 08/2/2021 09:00

People seem to be paying over the offer price.

[qs99] 08/2/2021 08:58

Full offer 1.06 now being paid....should be through £1.10 IMO shortly, as long as we don't see any more profit taking!

DYOR

[hooded claw] 08/2/2021 08:56

100p fully broken now :)

[bunz3] 08/2/2021 08:42

this volume of buys now that moved up to 1,03 ,looks like some buyers might have been waiting until £1 cleared or maybe more have read the rns




Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing

or even this part


David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.



"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."



The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations.

[bunz3] 08/2/2021 08:32

was good to see the sellers cleared around a £1 ,
now they look to be cleared £1,20 /150 might soon be seen with this buying pressure